NCT04089618 (MBLM-P) is a NA clinical trial of MBLM in Pain, Chronic, sponsored by Diakonie Kliniken Zschadraß.

Who is sponsoring NCT04089618?

NCT04089618 is sponsored by Diakonie Kliniken Zschadraß.

What drugs are being tested in NCT04089618?

Interventions in NCT04089618: MBLM.

What condition does NCT04089618 study?

NCT04089618 studies Pain, Chronic.

Is NCT04089618 still recruiting?

NCT04089618 is currently completed. Last updated 28 July 2020.

Last reviewed 2020-07-28 · How we verify

NCT04089618: MBLM-P

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meditation Based Lifestyle Modification in Chronic Pain

Completed NA Last updated 28 July 2020

What this trial tests

NA trial testing MBLM in Pain, Chronic in 22 participants. Completed in 31 January 2020.

Timeline

2 September 2019

Primary endpoint
31 January 2020

31 January 2020

Quick facts

Lead sponsor	Diakonie Kliniken Zschadraß
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	2 September 2019
Primary completion	31 January 2020
Estimated completion	31 January 2020
Sites	1 location across Germany

Drugs / interventions tested

MBLM

Conditions studied

Pain, Chronic — all drugs for Pain, Chronic →

Sponsor

Diakonie Kliniken Zschadraß

Who can join

18 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MBLM is a holistic therapy for people with mental disorders whose feasibility positive effects on patients with depression have already been demonstrated in clinical application and a piloted study. In the present trial, the feasibility and effect of MBLM on patients with chronic pain will be investigated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Yoga for chronic non-specific low back pain.
Wieland LS, Skoetz N, Pilkington K, Harbin S, et al · · 2022 · cited 29× · PMID 36398843 · DOI 10.1002/14651858.cd010671.pub3

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

NCT06800209 — Pain Reprocessing Therapy in Post-Operative Knee Pain · Phase 2 · recruiting
NCT06512727 — The PROACTIVE Study for Black Elders · NA · recruiting
NCT06837857 — Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain · Phase 2 · recruiting
NCT06541184 — Ziconotide for Non-cancer Pain by Intrathecal Administration · recruiting
NCT06592053 — Affecting Factors for Chronic Pain After Mastectomy · recruiting

Other Diakonie Kliniken Zschadraß trials

Trials by the same sponsor.

NCT04252976 — Meditation Based Lifestyle Modification in Healthy Individuals · NA · completed
NCT03652220 — Meditation Based Lifestyle Modification in Depression · NA · completed
NCT03004430 — Mantra Meditation in Major Depression · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04089618 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diakonie Kliniken Zschadraß
Last refreshed: 28 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04089618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing